MLKL attenuates colon inflammation and colitis-tumorigenesis via suppression of inflammatory responses

Area of Science:

• Immunology
• Molecular Biology
• Gastroenterology

Background:

• Mixed lineage kinase domain-like protein (MLKL) mediates necroptosis, releasing damage-associated molecular patterns (DAMPs).
• The precise role of MLKL in regulating intestinal inflammation and homeostasis remains incompletely understood.

Purpose of the Study:

• To investigate the physiological role of MLKL in intestinal inflammation and colitis-associated tumorigenesis (CAT).
• To elucidate the mechanisms by which MLKL influences inflammatory responses in the gut.

Main Methods:

• Utilized Mlkl knockout (Mlkl-/-) mice to assess susceptibility to colitis and CAT.
• Employed bone marrow transplantation to determine the cell-specific function of MLKL in colitis.
• Analyzed intestinal tissues and polyps for inflammatory markers, leukocyte infiltration, and signaling pathway activation (e.g., ERK).

Main Results:

• Mlkl-/- mice exhibited heightened susceptibility to colitis and CAT, characterized by significant leukocyte infiltration and elevated inflammatory responses.
• MLKL expression in inflammatory cells was found to be critical for protection against colitis.
• Absence of MLKL led to increased MEK/ERK activation, particularly in dendritic cells (DCs), contributing to enhanced intestinal inflammation.

Conclusions:

• MLKL plays a vital role in maintaining intestinal homeostasis.
• MLKL is protective against the development of colitis and colitis-associated tumorigenesis.
• Targeting MLKL or its downstream pathways may offer therapeutic strategies for inflammatory bowel diseases and associated cancers.